Full Professor in physical chemistry of drugs, Faculty of Health of Université Paris Cité (since 2021)
Accreditation to supervise research, i.e., HDR, hab. (2013)
Associate Professor in physical chemistry of drugs, Faculty of Health of the Université Paris Cité (2008 – 2021)
Post-doctorate :Warsaw University – Université de Lorraine – Total Pau – IFP énergies nouvelles Rueil-Malmaison (2005-2008)
CNRS Engineer Doctor in Physical chemistry, Material sciences and Process (2005)
Research themes
Yohann Corvis’ research within the Inserm/CNRS/UPCité Chemical and Biological Techniques for Health (UTCBS) Group focuses on formulating nanomedicines based on anticancer drugs, local anesthetics, and anti-inflammatories for targeted therapies and prolonged delivery of the active substance. He conceptualizes, develops, and evaluates the drugs in a biological environment using experimental platforms ranging from pre-formulation to in vivo animal evaluations.
Scientific production
57 publications, 3 journal covers, 3 international patents, 2 technical articles, 1 book chapter and 1 book review. Extensive list of publications here.
33 invited lectures
33 oral and 47 poster presentations (international conferences)
14 oral and 28 poster presentations (national conferences)
Editing responsibilities
Editorial Board Member of German Journal of Pharmaceuticals and Biomaterials (since 2024)
Guest Editor of International Journal of Pharmaceutics (2023)
Guest Editor of Pharmaceutics (2022)
Guest Editor of Frontiers in Chemistry (“Medicinal and Pharmaceutical Chemistry” section in 2020; “Green and Sustainable Chemistry” section in 2024)
Training through research
- PhD supervised
A. Hassan (2024-2027)
L. Castillo (2023-2026)
F. Oyoun (2021-2024)
P. Ma (2019-2023)
B. Martin (2016-2019) - PharmD thesis supervised
P. Begon de la Rouzière (2024-2025)
A. Kadouci (2023-2024)
I. Lim (2022-2023) - Internships supervised
71 students (Pharmacy, Engineering School, Master 2, Master 1, Licence 3, BTS, DUT)
Board of Faculty
External member of the Board of Faculty of Health Sciences, Iqra University North campus, Karachi, Pakistan (since 2023)
Commissions
Member of the D1Teaching Department (Chemistry and physico-chemistry of drugs) Directors board of the School of Pharmacy, Rank A representative (since 2024)
Member of the HDR (Accreditation to supervise research) Commission of the Faculty of Health of Université Paris Cité (since 2023)
Member of the Erasmus Mundus NANOMED Master’s steering committee (since 2023)
Scientific expertise
Foreign expert for PhD thesis evaluation from the School of Pharmacy of the University of Sindh, Pakistan (since 2023)
External member of the “Conseil Scientifique Inter Régional Grand-Ouest de La Ligue contre le cancer” (2022, 2024)
Scientific expert for HTL Biotechnology company (since 2022)
Expert for the French National Agency for Medicine and Health Product Safety (ANSM), in the frame of the Pharmacopoeia French Committee “Fourmulations of chemical, pharmaceutical and radiopharmaceutical substances” (since 2021)
Scientific expert for Septodont company (2016)
Learned societies
Elected board member of SFNano, the French Society for Nanomedicine (since 2021)
Elected board member and Treasurer of AECCPCM, the Society of the teachers and researchers of physical chemistry in Pharmacy (since 2013 and 2024, respectively)
International call evaluation
Croatian Science Foundation, HRZZ (2024)
National call evaluation
Institut des Nanosciences PSiNano (2024)
Agence Nationale de la Recherche, ANR (2023, 2024)
La Ligue contre le cancer (2022, 2024)
HDR evaluation
2024 : Health Faculty, Sorbonne Université
Member of PhD Monitoring Committee (CSI)
E. Chevé, Université Paris Cité (2023-2026)
PhD reviewer
- 2024
T. Ba To, Université Paris-Saclay
E. H. Abad, Université de Bourgogne Franche-Comté
S. El Masri, Université du Littoral Côte d’Opale
Y. Wu, Université Paris-Saclay
- 2023
G. Khalaf, Université Paris-Saclay
M. Sicot, Université d’Angers
M. Garnier, Sorbonne Université - 2021
M. Baroud, Université d’Angers
M. Rakatoarisoa, Université Paris-Saclay - 2020
R. Prasad, Indian Institute of Technology, Gandhinagar, India - 2016
W. Li, CentraleSupélec, Université Paris-Saclay - 2014
B. Clair, CentraleSupélec, Université Paris-Saclay - 2013
S. M. H. Sajjadi, Université de Lorraine
PhD examiner
- 2023
A. Libánská, University of Chemistry and Technology, Prague
Selection committee member
ITFA Doctoral School selection, Université Paris-Saclay (2024)
Students’ selection committee for the Master Erasmus Mundus NANOMED, Intake #8, Université Paris Cité (2024)
Jury member and internship reviewer, Master Pharmacotechnie, Université Paris Cité (since 2023)
Pharmacy students’ selection for the double training Pharmacy / Chimie Paris engineering school (since 2022)
PASS/L.AS oral sessions, Université Paris Cité (since 2021)
ParcourSup selection of the Learning Planet Institut’s L1 “Sodium” intake (2021)
PharmaSciences students’ selection, Université Paris Cité (2019, 2020, and 2022)
Pharmaceutical Studies Certificate, CSP, Université Paris Cité (2019 – 2021)
President of the Baccalauréat jury, Scientific séries, Lycée Richelieu, Rueil-Malmaison (2019)
Pluri-PASS oral sessions, Université d’Angers (2017)
Mid-term PhD thesis reviewer, ED MTCI, Université Paris Cité (2017, and 2022)
Pedagogic responsibilities, Université Paris Cité
Co-responsible for the Pharmacotechnie Master’s degree (since 2024)
Responsible for the “Alimentation et Santé” part, ECUE 2 teaching unit, PASS “Biotechbologie” minor (since 2023)
Co-responsible for the “Industrie Pharmaceutique et Innovation” teaching unit, L3 Sciences pour la santé (since 2022)
Co-responsible for the “Chimie et physico-chimie du médicament” teaching unit, L3 Sciences pour la santé (since 2022)
Co-responsible for the “Basic chemistry” and “Pré-formulation” courses, Master Erasmus Mundus NANOMED (since 2019)
Responsible for “État solide du médicament” practical work, M2 Phamacotechnie (since 2016)
Responsible for “Méthodes physico-chimiques avancées” practical work, M1 Spectroscopy (2013 – 2019)
Responsible for “De la matière première pharmaceutique au médicament” teaching unit, DFSP2 (since 2012)
Responsible for “État solide du médicament” practical work, M2 Produits de santé (since 2012)